Worldwide Genetic Cardiomyopathies Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4355264
- 124 Pages
- March 2021
- Healthcare
Genetic cardiomyopathies are acquired kind of medical condition of the heart muscles, a few of one of the most typical inherited problems and are a significant reason for heart disease in all age.
It is defined by the weakening of heart muscular tissues that makes it harder for the heart to pump blood to the remainder of the body. the major kinds of genetic cardiomyopathies are dilated, restrictive and also hypertonic cardiomyopathy.
The therapy of genetic cardiomyopathies include medicines, surgically implanted devices or a heart transplant. the market of genetic cardiomyopathies is anticipated to proliferate during the projection period as a result of the increasing number of heart issues and also increasing life expectations of individuals. the episode of coronavirus is an unprecedented shock to the worlds economic climate.
As coronavirus has come to be the main emphasis, all research institutes, biotech as well as pharmaceutical firms are selected in collaboration work to take care of covid-19. there has been a disturbance in the supply chain due to which production of implants as well as advancement of medicines is adversely affected.
Genetic cardiomyopathies market: drivers as well as restraints-
There are several factors that are driving the hereditary cardiomyopathies market, advancement in understanding and also managing of genetic cardiomyopathies is the major variable.
The raising need for very early diagnosis and also therapy of heart disease, cardiac arrest, and coronary cardiovascular disease is likely to drive the development of the genetic cardiomyopathies market.
Likewise, the enhancing use of minimally invasive innovation as well as accessibility of remote tracking remedies, clinical tourism in arising countries are expected to enhance the marketplace. aside from vehicle drivers, there are couple of restraints of genetic cardiomyopathies market such as high diagnosis as well as treatment cost and also lack of public recognition concerning various heart conditions.
Genetic cardiomyopathies market: introduction
Based upon the sort of condition, the dilated cardiomyopathy is expected to hold a major share in the hereditary cardiomyopathies market.
Based upon the medication type, the anticoagulant is one of the most preferred sector of the genetic cardiomyopathies market, anti-hypertensive medicine is anticipated to grow throughout the projection duration.
Based on the end-user, the medical facilities are anticipated to have the largest share in the international hereditary cardiomyopathies market.
Hereditary cardiomyopathies market: region-wise expectation
The United States and Canada and Europe are expected to control the international hereditary cardiomyopathies market, due to the raising occurrence of the cardiac condition, technical developments, as well as the visibility of crucial market gamers in the area.
Asia-pacific is anticipated to have a considerable growth in the worldwide hereditary cardiomyopathies market over the projection duration due to the increasing emphasis on precision medication, as well as rising understanding of heart disorders.
The enhancing population and changing way of life in countries like China and also India is further most likely to increase the need for genetic cardiomyopathies in the region.
The improvement in the innovations and also the growth of straight sarcomere modulators succeeds in offering a better and thorough understanding of the molecular devices.
Also, there has been a significant progression in drug treatment for the monitoring of genetic cardiomyopathies such as beta-andregenic blockers. there are lots of continuous scientific trials of numerous medications that would help to handle heart disorders in a much better means.
Genetic cardiomyopathies market: vital market individuals
Several of the marketplace individuals in the global hereditary cardiomyopathies market identified throughout the value chain consist of:
Novartis global ag
Merck & co. teva drugs markets ltd.
Mylan n.v
Bristol myers squibb firm
Boston clinical corporation
Becton
Dickinson and business
Vital treatment diagnostics inc.
Labcorp
Perkinelmer
Sofina
Bio-rad research laboratories inc.
Roche holding ag
Astrazeneca plc
Sanofi s.a
Myokardia
Phasebio
The report covers exhaust evaluation on:
Hereditary cardiomyopathies market segments
Genetic cardiomyopathies market characteristics
Market dimension
Supply & need existing trends/issues/challenges
Competition & firms involved
Technology
Worth chain
Local analysis includes:
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, UK, Spain)
Eastern Europe (Poland, Russia)
Asia pacific (India, ASEAN, Australia & New Zealand)
China
Japan
Center eastern and also Africa (GCC Countries, s. Africa, northern Africa)
Report highlights:
Thorough overview of moms and dad market
Changing hereditary cardiomyopathies market characteristics in the industry
Hereditary cardiomyopathies -deepness market division
Historic, current, as well as projected market size in regards to volume as well as value
Hereditary cardiomyopathies industry trends and growths
Competitive landscape
Strategies of crucial gamers as well as products used
Potential and specific niche sections, geographical areas exhibiting promising development
A neutral point of view on market efficiency
Essential info for market gamers to sustain as well as improve their market footprint
Genetic cardiomyopathies market: division
By disease kind:
Dilated cardiomyopathy
Limiting cardiomyopathy
Hypertonic cardiomyopathy
Others
By medicine kind:
Anticoagulants
Anti-hypertensives
Antiarrhythmics
Cardiac glycosides
Others
By end-user:
Hospitals
Centers
Ambulatory solution centres
Others
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Genetic Cardiomyopathies by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Genetic Cardiomyopathies Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Genetic Cardiomyopathies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Genetic Cardiomyopathies Production from 2014-2020
4.3.1.2 North America Genetic Cardiomyopathies Consumption from 2014-2020
4.3.1.3 North America Genetic Cardiomyopathies Import and Export from 2014-2020
4.3.1.4 North America Genetic Cardiomyopathies Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Genetic Cardiomyopathies Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Genetic Cardiomyopathies Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Genetic Cardiomyopathies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Genetic Cardiomyopathies Production from 2014-2020
4.3.2.2 Europe Genetic Cardiomyopathies Consumption from 2014-2020
4.3.2.3 Europe Genetic Cardiomyopathies Import and Export from 2014-2020
4.3.2.4 Europe Genetic Cardiomyopathies Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Genetic Cardiomyopathies Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Genetic Cardiomyopathies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Genetic Cardiomyopathies Production from 2014-2020
4.3.3.2 Asia-Pacific Genetic Cardiomyopathies Consumption from 2014-2020
4.3.3.3 Asia-Pacific Genetic Cardiomyopathies Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Genetic Cardiomyopathies Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Genetic Cardiomyopathies Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Genetic Cardiomyopathies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Genetic Cardiomyopathies Production from 2014-2020
4.3.4.2 Latin America Genetic Cardiomyopathies Consumption from 2014-2020
4.3.4.3 Latin America Genetic Cardiomyopathies Import and Export from 2014-2020
4.3.4.4 Latin America Genetic Cardiomyopathies Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Genetic Cardiomyopathies Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Genetic Cardiomyopathies Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Genetic Cardiomyopathies Production from 2014-2020
4.3.5.2 Middle East & Africa Genetic Cardiomyopathies Consumption from 2014-2020
4.3.5.3 Middle East & Africa Genetic Cardiomyopathies Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Genetic Cardiomyopathies Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Genetic Cardiomyopathies Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Genetic Cardiomyopathies Market from 2020-2026
7.1 Future Forecast of Global Genetic Cardiomyopathies Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Genetic Cardiomyopathies Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Genetic Cardiomyopathies Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
785 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Genetic Cardiomyopathies Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Genetic Cardiomyopathies Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Genetic Cardiomyopathies
Figure Type 2 of Genetic Cardiomyopathies
Figure Type 3 of Genetic Cardiomyopathies
Table Global Genetic Cardiomyopathies Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Genetic Cardiomyopathies Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Genetic Cardiomyopathies
Figure Application 2 of Genetic Cardiomyopathies
Figure Application 3 of Genetic Cardiomyopathies
Table Global Genetic Cardiomyopathies Production Value ($) by Regions
Table Global Genetic Cardiomyopathies Production Value Share by Regions
Table Global Genetic Cardiomyopathies Production by Regions
Table Global Genetic Cardiomyopathies Production Share by Regions
Table Global Genetic Cardiomyopathies Consumption by Regions
Table Global Genetic Cardiomyopathies Consumption Share by Regions
Figure North America Genetic Cardiomyopathies Production and Growth Rate from 2014-2020
Figure North America Genetic Cardiomyopathies Consumption and Growth Rate from 2014-2020
Table North America Genetic Cardiomyopathies Import and Export from 2014-2020
Table North America Genetic Cardiomyopathies Value ($) and Growth (%) by Type from 2019-2020
Table North America Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
Table North America Genetic Cardiomyopathies Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
Figure Europe Genetic Cardiomyopathies Production and Growth Rate from 2014-2020
Figure Europe Genetic Cardiomyopathies Consumption and Growth Rate from 2014-2020
Table Europe Genetic Cardiomyopathies Import and Export from 2014-2020
Table Europe Genetic Cardiomyopathies Value ($) and Growth (%) by Type from 2019-2020
Table Europe Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
Table Europe Genetic Cardiomyopathies Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Genetic Cardiomyopathies Production and Growth Rate from 2014-2020
Figure Asia-Pacific Genetic Cardiomyopathies Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Genetic Cardiomyopathies Import and Export from 2014-2020
Table Asia-Pacific Genetic Cardiomyopathies Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Genetic Cardiomyopathies Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
Figure Latin America Genetic Cardiomyopathies Production and Growth Rate from 2014-2020
Figure Latin America Genetic Cardiomyopathies Consumption and Growth Rate from 2014-2020
Table Latin America Genetic Cardiomyopathies Import and Export from 2014-2020
Table Latin America Genetic Cardiomyopathies Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Genetic Cardiomyopathies Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Genetic Cardiomyopathies Production and Growth Rate from 2014-2020
Figure Middle East & Africa Genetic Cardiomyopathies Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Genetic Cardiomyopathies Import and Export from 2014-2020
Table Middle East & Africa Genetic Cardiomyopathies Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Genetic Cardiomyopathies Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Genetic Cardiomyopathies Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Genetic Cardiomyopathies Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Genetic Cardiomyopathies Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Genetic Cardiomyopathies Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Genetic Cardiomyopathies Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Genetic Cardiomyopathies Production and Growth Rate Forecast by Types (2020-2026)
Table Global Genetic Cardiomyopathies Consumption and Growth Rate Forecast by End-User/Applications (2020-2802)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
